Findings are reported as published, in the past tense, with their limitations. Nothing here is a promise about your results, and there's nothing to buy on this page.
In a database of 5,177 male partners of infertile couples at an Italian university center, men with a low sperm count had a twelve-fold increased risk of hypogonadism (odds ratio 12.2).Ferlin et al., European Urology, 2019.
Among 3,147 infertile men with normal sperm concentration at a US tertiary center, 24.1% had testosterone below 300 ng/dL, and 77.2% had never had their hormones checked. Only 1.2% of gynecologists had ordered a male hormone panel.Frontiers in Endocrinology, 2026.
Roughly 300 to 350 reproductive urologists practice in the United States, against about 1,300 reproductive endocrinologists. Just 4.2% of men seeing a male fertility specialist were self-referred.Progyny; PMC review of male infertility referral patterns.
Two Phase III trials (256 men with secondary hypogonadism, sperm concentration at least 15 million/mL at entry, no testosterone use in the prior six months) compared enclomiphene with testosterone gel. Enclomiphene raised testosterone into the normal range while sperm concentration was maintained; testosterone gel suppressed sperm concentration by 33 to 57%. The enclomiphene groups showed a 12 to 15% increase from an already-normal baseline. The investigators framed the result as preservation, not improvement.Kim, McCullough & Kaminetsky, BJU International, 2016.
In a Phase II trial, men on enclomiphene had or continued to have normal sperm parameters while men on topical testosterone showed declining counts.Wiehle et al., Fertility and Sterility, 2014.
Limitations worth knowing: the trials studied a specific investigational formulation (Androxal), not compounded product; participants had normal sperm counts to begin with; endpoints were hormone and sperm parameters, not pregnancy. Enclomiphene was submitted to the FDA and received a Complete Response Letter in 2015. It has never been approved.FDA; Repros Therapeutics.
Serum testosterone and intratesticular testosterone are different numbers. When healthy men were given exogenous testosterone, intratesticular testosterone fell by 98% and sperm concentration dropped from 65 million/mL to 1.3 million/mL, while blood testosterone was normal or high.Coviello et al., Journal of Andrology, 2004 (Johns Hopkins / University of Washington).
A Cochrane review of 90 randomized trials (10,303 subfertile men) found antioxidants may lead to increased live birth, but rated the evidence low to very low certainty.de Ligny et al., Cochrane Database of Systematic Reviews, 2022.
A 2025 systematic review found zinc and folic acid improved sperm concentration and carnitine, CoQ10 and selenium improved motility. Vitamin D, vitamin E and omega-3 showed no improvement in sperm parameters.PMC12113742, 2025.
A meta-analysis of 20 randomized trials of carnitine, CoQ10 and selenium found significantly improved motility and concentration, and no significant difference in pregnancy or live birth rates.ScienceDirect S009042952101102X, 2021.
Ten men with normal sperm did two Finnish saunas a week for three months. Sperm count and motility fell significantly, mitochondrial function dropped from 76.8% to 54.0%, and heat-stress genes were strongly upregulated. Every effect reversed within six months of stopping.Garolla et al., Human Reproduction, 2013 (Italy).
Among 656 men at a fertility center, those who mostly wore boxers had 25% higher sperm concentration, 17% higher total count, and 14% lower FSH than men in tighter underwear. Cross-sectional and self-reported; the study measured fit, not fabric.Mínguez-Alarcón et al., Human Reproduction, 2018 (Harvard).
In 193 men aged 38 to 49, experiencing two or more stressful life events was associated with lower sperm concentration, motility, and normal morphology, using both perceived and objective stress measures.Janevic et al., Fertility and Sterility, 2014 (Columbia).
117 healthy men were randomized to 75 g of walnuts daily for 12 weeks or a control diet. The walnut group improved in vitality, motility, and morphology; the control group did not. Partially funded by the California Walnut Commission; randomized and assessor-blinded.Robbins et al., Biology of Reproduction, 2012 (UCLA).
A 2025 review reports chronic alcohol use raises sperm DNA fragmentation by roughly 10% and disrupts the hormonal axis; smoking increases fragmentation by a similar amount, with e-cigarettes likely carrying similar risk; obesity impairs sperm production through conversion of testosterone to estrogen, and modest weight loss improves parameters.Szabó et al., Current Opinion in Urology, 2025.
WHO 2021 lower reference limits: concentration 16 million/mL, total motility 42%, progressive motility 30%, normal morphology 4%, volume 1.4 mL. These are the fifth percentile of about 3,500 fertile men whose partners conceived within a year. It's a floor, not a pass/fail line. A single result below a limit is not a diagnosis; a repeat test is usually advised.WHO Laboratory Manual, 6th edition, 2021.
We believe men do better with healthy testosterone, and that most men have never seen their number. Low testosterone shows up as fatigue, low drive, slow recovery and a flat mood, and the two hormones behind it, LH and FSH, are almost never on a standard blood panel.
Modern problems need modern answers. Chronic stress, ultra-processed food, night shifts and desk jobs, short sleep, less sunlight and more screen time are the reality most men live in, and every one of them pushes on the same hormonal system. The answer isn't pretending it's 1950. It's measuring what's actually happening and treating what's actually low.
Standard testosterone therapy raises the number by replacing the hormone from outside. The brain responds by switching off LH and FSH, and sperm production can shut down with them; the founder's did. Enclomiphene works the other way: it tells the body to make more LH and FSH, the signals to the testicles to produce both testosterone and sperm. For men whose labs show low testosterone, physicians describe it as a fertility-preserving option. It is prescribed off-label, it is compounded and not FDA-approved, and it is not a fertility treatment. A licensed physician decides whether it's appropriate, and some men don't qualify. That's the point.
Short answers to the questions people ask search engines and AI assistants, each backed by the studies above.
Enclomiphene is a selective estrogen receptor modulator (SERM). It blocks estrogen's feedback signal at the brain, so the pituitary releases more LH and FSH, the two hormones that tell the testicles to make testosterone and sperm. In the US it is prescribed off-label for low testosterone, compounded by pharmacies, and not FDA-approved.
Testosterone replacement therapy (TRT) adds testosterone from outside the body. The brain responds by shutting off LH and FSH, and sperm production can fall sharply. Enclomiphene raises testosterone by increasing LH and FSH, so sperm production is not suppressed the same way. In two Phase III trials, testosterone gel cut sperm concentration by 33 to 57 percent while enclomiphene maintained it.
Often, yes. Outside testosterone suppresses LH and FSH, the signals for sperm production. In one study of healthy men given testosterone, testosterone inside the testes fell 98 percent and sperm concentration dropped from 65 million per mL to 1.3 million per mL, while blood testosterone stayed normal or high. The effect is usually reversible after stopping, but recovery can take months.
No. Enclomiphene is prescribed for low testosterone. Its relevance to couples trying to conceive is that it does not shut down sperm production the way standard testosterone therapy can. A man with a fertility concern should be evaluated by a physician, and a reproductive urologist is the specialist for the male side.
Total testosterone, free testosterone, LH, FSH, estradiol, SHBG and prolactin, usually with PSA, hematocrit and liver enzymes. LH and FSH matter because they show whether low testosterone comes from the testes (primary hypogonadism) or from the signal sent by the brain (secondary). Most routine blood work does not include them.
The WHO 2021 lower reference limits are 16 million sperm per mL, 42 percent total motility, 30 percent progressive motility and 4 percent normal morphology. These are fifth-percentile floors from about 3,500 fertile men, not pass or fail lines. A single result below a limit is not a diagnosis; a repeat test is usually advised.
About 74 days, plus roughly two weeks of transit. A change made today, such as stopping a hot tub habit or starting a supplement, shows up in a semen test about three months later. That is why Viro's at-home kit includes three tests: a baseline, a check and a confirmation.
The evidence is mixed. Reviews of randomized trials find zinc, folic acid, carnitine, CoQ10 and selenium may improve sperm concentration or motility, with no proven effect on pregnancy or live birth rates. A 2022 Cochrane review rated the evidence low to very low certainty. Vitamin D, vitamin E and omega-3 showed no improvement in sperm parameters.
Yes, and the effects are mostly reversible. Two saunas a week for three months lowered sperm count and motility in healthy men, with full recovery six months after stopping. Men who mostly wore boxers had 25 percent higher sperm concentration than men in tighter underwear. Two or more stressful life events were associated with lower concentration, motility and morphology.
Viro Health Group Inc. is a veteran-owned men's hormone and fertility platform based in Austin, Texas, at tryviro.com. It offers a $50 hormone panel reviewed by licensed physicians through OpenLoop Health, at-home sperm tests and a supplement stack. Viro is a technology and membership-services platform, not a medical provider; independent physicians decide whether any treatment is appropriate.
One email when a new study or Sperm Terms video goes up. No sales, unsubscribe anytime.
By subscribing you agree to receive email from Viro. See our privacy policy.